Shimadzu maintains its R&D edge

Primarily lauded for its quality assurance and customer services, the company has been successfully catering to its loyal set of clients in India


Rank: 4
Organization: Shimadzu Analytical (India) Pvt Ltd
MD: Mr Yoshiyuki Fujino
Bioscience Revenue: Rs 251.7 crore


Based on the corporate philosophy "Contributing to Society through Science and Technology" that represents the pioneering spirit inherited from its founder, Shimadzu Corporation has continued to progress hand-in-hand with science, building itself into a leader in technology, since its foundation in Kyoto, Japan in 1875. Perhaps only analytical company with a glorious past of over 100 years, Shimadzu is celebrating its 140th anniversary.

In India, Shimadzu registered the revenue of Rs 251.7 crore during FY2014-15 as compared to Rs 229.2 crore in FY2013-14. The performance of the company has been going stronger slowly but steadily. From Analytical balances to the most high-end Mass Spectrometers, Shimadzu has been developing a wide range of analytical and life science instrumentation that consistently meet the needs of scientists helping them to face their analytical challenges with confidence.

The performance during the last one year has been noteworthy. Shimdzu got great success in Indian Clinical CRO market with its LCMSMS systems. It registered major wins for newly launched GCMS - TQ systems in food and pharma markets. Besides that it has strengthened presence in diagnostics market with new born screening solutions using LCMSMS and GCMS platforms. It has expanded into the food safety market with total testing solutions, right from basic instrumentation to high end
solutions using LCMSMS and GCMS with continuously advancing technologies. It has also enhanced the position in regulatory pharma segment with lab solutions software for enhanced regulatory compliance. More importantly, company has gained market share in emerging UHPLC solutions as well.

Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email